切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Ferroptosis - c-Fyn - Neuraminidases (NA) - ErbB

10 件产品

每页
清除全部
  1. Mubritinib (TAK 165)
    B1543 Mubritinib (TAK 165)
    中文名: 木利替尼
    Target: ErbB
    Summary: HER2/ErbB2有效抑制剂
      ≥76.9 mg/mL
      insoluble in H2O
  2. Oseltamivir phosphate
    B1803 Oseltamivir phosphate
     1 Citation
    中文名: 磷酸奥司他韦
    Target: Neuraminidases (NA)
    Summary: 有效的选择性神经氨酸酶抑制剂
      ≥20.3 mg/mL
      ≥110 mg/mL
  3. 1-NM-PP1
    B1299 1-NM-PP1
    Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-Fyn
    Summary: Pp60c-src抑制剂
      ≥16.55 mg/mL
      insoluble in H2O
  4. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    中文名: 沙普替尼
    Target: EGFR|ErbB
    Summary: ErbB抑制剂
      ≥23.7 mg/mL
      insoluble in H2O
  5. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    中文名: 达克替尼
    Target: ErbB
    Summary: HER抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  6. Lapatinib
    A8218 Lapatinib
     2 Citation
    中文名: 拉帕替尼
    Target: ErbB
    Summary: EGFR/HER2抑制剂
      ≥29.05 mg/mL
      insoluble in H2O
  7. X-NeuNAc
    A3944 X-NeuNAc
    Target: Neuraminidases (NA)
    Summary: 神经氨酸酶活性显色试验的底物
      ≥28 mg/mL
      ≥19.9 mg/mL
  8. Oseltamivir acid
    A3689 Oseltamivir acid
     1 Citation
    中文名: 奥斯他伟酸,奥司他韦羧酸,奥司他韦酸,奥塞米韦酸
    Target: Neuraminidases (NA)
    Summary: 流感神经氨酸酶抑制剂
      ≥14.2 mg/mL
      ≥46.1 mg/mL
  9. Ferrostatin-1 (Fer-1)
    A4371 Ferrostatin-1 (Fer-1)
    Target: Ferroptosis
    Summary: Erastin诱导的Ferroptosis抑制剂
      ≥149 mg/mL
      insoluble in H2O
  10. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: 多靶点HDAC抑制剂
      ≥21.7 mg/mL
      insoluble in H2O

10 件产品

每页